2005
DOI: 10.1183/09031936.05.00088304
|View full text |Cite
|
Sign up to set email alerts
|

Dry cough and dyspnoea rapidly increasing to respiratory failure in a male smoker

Abstract: A 65-yr-old male, current smoker of .30 cigarettes?day -1 (total smoking history 150 pack-yrs), who was working as a bus driver, presented at the Evangelismos Hospital (Athens, Greece) complaining of increasing breathlessness on exertion and dry cough during the past 2 months. He had no animal exposure and he hadn't travelled abroad during the last few years. His medical history showed arterial hypertension, for which he was receiving treatment with an angiotension-converting enzymeinhibitor (ramipril) plus hy… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
3
0

Year Published

2006
2006
2020
2020

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 7 publications
(3 citation statements)
references
References 16 publications
0
3
0
Order By: Relevance
“…Data on cellularity of BAL in DIP was scarce (it was only available in eight out of the 68 cases and in two series) [7,12,14,18,21,24,46,48,77,78]. BAL generally demonstrated high numbers of pigmented macrophages, but with a considerable range.…”
Section: Bronchoscopymentioning
confidence: 97%
“…Data on cellularity of BAL in DIP was scarce (it was only available in eight out of the 68 cases and in two series) [7,12,14,18,21,24,46,48,77,78]. BAL generally demonstrated high numbers of pigmented macrophages, but with a considerable range.…”
Section: Bronchoscopymentioning
confidence: 97%
“…Bibasilar endinspiratory crackles and cyanosis are frequently present, and clubbing is not rare [1,3,5,6,10]. Thus, DIP is classically characterised by an insidious onset of symptoms but may present as a fulminant or rapidly progressive disease [11][12][13]. The epidemiological and clinical features of DIP are summarised in table 1.…”
Section: Epidemiological and Clinical Featuresmentioning
confidence: 99%
“…On the other hand in COP and CEP, corticosteroids constitute a secure choice assuring that tapering and low-dose corticosteroid maintenance may obviate toxicity and recurrence, respectively [39][40][41] . In the setting of desquamative interstitial pneumonia, considerable therapeutic uncertainty remains, especially in nonsmokers, though clinicians are prone to use corticosteroids [42,43] . Finally, LIP is both sensitive to corticosteroids and rituximab [44] .…”
Section: Rheumatoid Arthritismentioning
confidence: 99%